Introduction
Preeclampsia (PE) remains a significant challenge in obstetric medicine, affecting approximately 5–7% of pregnancies and serving as a leading cause of maternal and neonatal morbidity. Characterized by hypertension and proteinuria after 20 weeks of gestation, the etiology of PE is complex and often attributed to abnormal placental development. Recent research has pivoted toward epigenetic mechanisms—specifically DNA methylation—to understand how gene expression is regulated in the preeclamptic placenta without altering the underlying genetic code. This study investigates whether PE is associated with global genomic hypermethylation and specific alterations in the paternally imprinted H19 gene, a known regulator of placental growth.
Methods
The researchers analyzed placental tissues from 48 women, categorized into normal controls (n=24), early-onset PE (E-PE, <34 weeks, n=10), and late-onset PE (L-PE, >34 weeks, n=14). Global DNA methylation was assessed using pyrosequencing of Alu and LINE-1 repetitive elements, which serve as surrogates for the entire genome. Additionally, immunohistochemistry (IHC) for 5-methylcytosine (5-MC) provided visual quantification of methylation. The methylation status of the H19 gene promoter was determined via Methylation-Sensitive High-Resolution Melting (MS-HRM), while real-time PCR measured the expression levels of H19 mRNA and DNA methyltransferases (DNMTs).
Results
Global DNA Hypermethylation in Early-Onset PE
A primary finding of the study was a significant increase in global DNA methylation levels specifically within the early-onset PE group. Pyrosequencing of repetitive elements revealed that both Alu and LINE-1 methylation were significantly higher in E-PE placentas compared to normal controls ($P=0.0054$ and $P=0.0016$, respectively). Interestingly, these changes were not observed in late-onset PE, suggesting distinct biological pathways for the two clinical subtypes.
DNMT1 Overexpression and H19 Gene Silencing
The study identified a potential mechanism for this hypermethylation: the overexpression of DNMT1, the enzyme responsible for maintaining DNA methylation patterns. DNMT1 mRNA levels were significantly elevated in E-PE placentas ($0.7523 \pm 0.2135$) relative to controls ($0.3020 \pm 0.0711$).
This enzymatic upregulation correlated with the hypermethylation of the H19 gene promoter. In E-PE cases, H19 promoter methylation reached $57.19\% \pm 2.068\%$, compared to $47.87\% \pm 1.678\%$ in controls. This epigenetic "over-tagging" led to a dramatic reduction in H19 expression, with mRNA levels approximately five times lower in E-PE placentas ($P=0.0034$).
Discussion
The findings underscore the importance of epigenetic dysregulation in the pathogenesis of early-onset preeclampsia. The silencing of H19, a non-coding RNA critical for placental cell invasion, likely contributes to the poor placentation characteristic of the disease. Furthermore, the link between DNMT1 levels and global methylation suggests that maternal environmental factors influencing methyl donor availability (such as folate or choline) could play a role in triggering these epigenetic shifts. While the small sample size of the E-PE cohort is a limitation, the clear distinction between early- and late-onset cases provides a valuable framework for future diagnostic and therapeutic research.
Summary updated